In 2023, more than 1,200 kids between the ages of 12 and 17 were prescribed semaglutide for obesity, according to an analysis of insurance claims by Komodo Health. Additionally, when data from Medicaid programs in 5 selected states was analyzed by Reuters, more than 460 children were found to be taking the weight management drug. The bottom line seems to indicate that providers are embracing obesity pharmacotherapy for tweens. Of note, it was December 2022 …
Read More